a more favorable option for some patients Side Effects: Black Box Warning: RISK OF THYROID C-CELL TUMORS Reference: rxlist.com (Tanzeum) Dulaglutide Drug Name: Trulicity (FDA Approved 9/18/14) GLP-1 receptor agonist, hypoglycemic Pharmacokinetics: Long acting (half life: 5 days) subcutaneous pen injections weekly dosing (vs daily dosing for some other GLP-1 agonists such as exenatide, liraglutide & lixisenatide) a more favorable dosing option for some patients Side Effects: Black Box Warning: RISK OF THYROID C-CELL TUMORS References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)
Never adjust your dose or injection frequency without consulting us first
We provide ongoing monitoring to ensure safety and effectiveness
A more gradual approach may be recommended if you: Have experienced nausea with GLP-1 medications before Are sensitive to appetite suppressants Have a history of digestive issues Prefer a gentler adjustment period In these cases, remaining on the starting dose longer, or increasing in smaller steps, can significantly improve comfort
13 , 1759720X211015006 (2021)
That would be manufactured urgency, and this article doesn't do that
